About 23Mofang
23Mofang is a Healthcare company based in Chengdu (China) founded in 2015. It provides genetic testing services to help prevent potential problems and early intervention. 23Mofang has raised $34.25 million across 5 funding rounds from investors including Hanwang, CD Capital and SBCVC. Its website 23mofang.com draws about 103 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its competitors include CircleDNA, WeGene and GeseDNA; 1 of its 3 listed competitors has raised funding.
Company details
23Mofang was founded in 2015 in Chengdu, China, within the genetic testing sector. Services are delivered to assess health risks and physical characteristics via genetic analysis. International quality control standards are followed, with global research data incorporated for genetic interpretation. Operations are based in China, supporting users in early health interventions and risk identification.
- Headquarters Chengdu, China
- SectorsHealthcare
- Website 23mofang.com
- Total Equity Funding$34.25M (USD)
in 5 rounds
- Latest Funding Round$9.65M (USD), Series B
May 2018
- InvestorsHanwang
& 8 more
Funding Insights of 23Mofang
23Mofang has successfully raised a total of $34.25M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $9.65 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.25M
- Total Rounds 5
- Last Round Series B — $9.65M
- Investors Count 9
All 5 funding rounds of 23Mofang with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $9.65M | Series B | – | CD Capital, SBCVC | – |
| Mar 2018 | $15.77M | Series B | – | Matrix Partners China | |
| Aug 2017 | $5.95M | Series B | – | Hanwang | |
| Jan 2017 | $2.88M | Series A | – | – | – |
| Jan 2016 | Seed | – | Beijing Singularity Leading Equity Investment Management, Fenghou Capital | – |
9 investors in total: 9 institutional.
Investors in 23Mofang
23Mofang has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Hanwang, CD Capital and SBCVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| cd-pe.com | ||||
China-based startups are invested in by SBCVC across diverse sectors. | sbcvc.com | Shanghai, China | ||
Tech & Life Science focused early & growth stage VC firm investing in the US & China | 3ebiovc.com | Beijing, China | ||
Multiple sectors are invested in by this venture capital firm. | matrixpartners.com.cn | Chaoyang, China | ||
| desunfund.com | ||||
Manages diversified investment portfolios across various asset classes. | 1999 | desungroup.com | Chengdu, China | |
Handwriting recognition technologies are developed by Hanwang. | 1998 | hanwang.com.cn | Beijing, China | |
FengHou Capital is engaged in early-stage equity investments in China. | 2013 | fhcapital.com | China | |
| sglcapital.com.cn |
Investor details for 23Mofang
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of 23Mofang
3 dated milestones of 23Mofang across 3 years, from founding to its latest funding, stage changes and deals.
- Founded 23Mofang is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $9.7M.
Competitors of 23Mofang
23Mofang has 3 listed competitors in our database, 1 of them funded. They include CircleDNA, WeGene and GeseDNA.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| circledna.com | 2014 | Hong Kong, China | $15M | Internet-first platform for genetic diagnostics is provided. | ||
| wegene.com | 2014 | Shenzhen, China | Genetic testing is conducted using saliva for health risk detection. | |||
| gesedna.com | 2014 | Beijing, China | Gene detection tools and DNA interpretation services are provided. |
Detailed competitors of 23Mofang
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 23Mofang
The website of 23Mofang (23mofang.com) receives about 102.8K visits a month.
- Monthly visits102.8K
▼ 2.5% vs previous month
Websites whose visitors overlap most with 23Mofang. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| wegene.com | 100% | 34.3K | #566,378 | View details | |
jiapu.tv | jiapu.tv | 95% | #380,274 | – | |
zupu.cn | zupu.cn | 92% | #297,213 | – | |
dezhoudaily.com | dezhoudaily.com | 82% | #1,948,565 | – | |
tech.creaders.net | tech.creaders.net | 78% | #327,496 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for 23Mofang
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 23Mofang
23Mofang was founded in 2015 and raised its 1st funding round 1 year after it was founded.
23Mofang is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.
23Mofang is a funded company, having raised a total of $34.25M across 5 funding rounds to date.
23Mofang was founded in 2015 in Chengdu, China, within the genetic testing sector. Services are delivered to assess health risks and physical characteristics via genetic analysis. International quality control standards are followed, with global research data incorporated for genetic interpretation. Operations are based in China, supporting users in early health interventions and risk identification.
23Mofang has 9 investors. Key investors include Hanwang, CD Capital, SBCVC, 3E Bioventures Capital, and Matrix Partners China.
The website of 23Mofang receives about 103 thousand visits a month.